Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Clinical trial NCT04088032 · WITHDRAWN

Trial details

NCT number: NCT04088032
Sponsor: Alison Stopeck
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Female Locally Advanced Breast Cancer Hormone Receptor Positive Malignant Neoplasm of Breast

Start date: 2019-10-01
Primary completion: 2020-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.